Tudor Investment Corp’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,622
Closed -$414K 1779
2023
Q1
$414K Sell
5,622
-4,322
-43% -$318K 0.01% 1188
2022
Q4
$664K Buy
+9,944
New +$664K 0.01% 1021
2022
Q1
Sell
-5,311
Closed -$512K 1779
2021
Q4
$512K Buy
+5,311
New +$512K 0.01% 1144
2021
Q2
Sell
-5,343
Closed -$508K 1670
2021
Q1
$508K Sell
5,343
-17,320
-76% -$1.65M 0.01% 1119
2020
Q4
$1.41M Buy
22,663
+14,021
+162% +$870K 0.04% 552
2020
Q3
$514K Buy
+8,642
New +$514K 0.02% 801
2020
Q1
Sell
-9,277
Closed -$604K 1195
2019
Q4
$604K Buy
9,277
+5,532
+148% +$360K 0.03% 653
2019
Q3
$233K Sell
3,745
-24,402
-87% -$1.52M 0.01% 917
2019
Q2
$2M Buy
28,147
+9,894
+54% +$704K 0.06% 326
2019
Q1
$1.43M Sell
18,253
-30,529
-63% -$2.39M 0.06% 347
2018
Q4
$4.13M Buy
+48,782
New +$4.13M 0.08% 62
2018
Q3
Sell
-8,534
Closed -$1.1M 1159
2018
Q2
$1.1M Buy
8,534
+5,961
+232% +$770K 0.04% 398
2018
Q1
$265K Buy
+2,573
New +$265K 0.01% 768
2016
Q4
Sell
-3,687
Closed -$235K 1499
2016
Q3
$235K Sell
3,687
-3,366
-48% -$215K 0.01% 1151
2016
Q2
$525K Buy
7,053
+801
+13% +$59.6K 0.01% 665
2016
Q1
$418K Buy
6,252
+2,296
+58% +$154K 0.01% 878
2015
Q4
$268K Buy
+3,956
New +$268K 0.01% 1136
2014
Q4
Sell
-8,336
Closed -$244K 1518
2014
Q3
$244K Buy
+8,336
New +$244K 0.01% 1102
2014
Q2
Sell
-6,816
Closed -$286K 1231
2014
Q1
$286K Buy
+6,816
New +$286K 0.01% 827
2013
Q4
Sell
-18,755
Closed -$506K 1307
2013
Q3
$506K Buy
+18,755
New +$506K 0.02% 331